Should the duration of primary hyperparathyroidism impact guidelines for evaluation and treatment?

被引：4
|
作者：
Randle, Reese W. [1 ]
Lee, Cortney Y. [1 ]
机构：
[1] Univ Kentucky, Dept Surg, Sect Endocrine Surg, 125 E Maxwell St,Suite 302, Lexington, KY 40508 USA
来源：
SURGERY | 2019年 / 165卷 / 01期
关键词：
MANAGEMENT;
D O I：
10.1016/j.surg.2018.07.044
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：105 / 106
页数：2
相关论文
共 50 条
  • [1] Disagreement: Should the duration of primary hyperparathyroidism impact guidelines for evaluation and treatment?
    Singh, Kavindra
    Khattar, Manish
    Kumar, Chitresh
    SURGERY, 2019, 166 (05) : 949 - 950
  • [2] Evaluation and treatment of primary hyperparathyroidism
    Grey, A
    Bolland, M
    Reid, IR
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (21): : 2699 - 2700
  • [3] Guidelines on Diagnosis, Evaluation, and Management of Primary Hyperparathyroidism, 2021
    Bilezikian, John P.
    Silverberg, Shonni J.
    Brandi, Maria Luisa
    Clarke, Bart L.
    Fuleihan, Ghada El-Hajj
    Marcocci, Claudio
    Minisola, Salvatore
    Perrier, Nancy
    Thakker, Rajesh
    Serra, Antonio Sitges
    Ye, Khikang
    Guyatt, Gordon
    Mannstadt, Michael
    Potts, John T.
    Khan, Aliya A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 273 - 273
  • [4] Methodology for the Guidelines on Evaluation and Management of Hypoparathyroidism and Primary Hyperparathyroidism
    Yao, Liang
    Guyatt, Gordon
    Ye, Zhikang
    Bilezikian, John P.
    Brandi, Maria Luisa
    Clarke, Bart L.
    Mannstadt, Michael
    Khan, Aliya A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 (11) : 2404 - 2410
  • [5] GUIDELINES FOR MANAGEMENT OF PRIMARY HYPERPARATHYROIDISM
    Lazaretti-Castro, M.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S48 - S48
  • [6] CLINICAL EXPERIENCE WITH PRIMARY HYPERPARATHYROIDISM - EVALUATION OF TREATMENT
    GOLDSMITH, RE
    ZALME, E
    WEINSTEIN, AS
    ACTA ENDOCRINOLOGICA, 1966, 52 (02): : 221 - +
  • [7] Quality appraisal of clinical practice guidelines for the evaluation and management of primary hyperparathyroidism
    Salmon, Mandy K.
    Fritz, Christian G.
    Barrette, Louis-Xavier
    Romeo, Dominic
    Suresh, Neeraj V.
    Ng, Jinggang J.
    Balar, Eesha
    Prasad, Aman
    Moreira, Alvaro
    Rajasekaran, Karthik
    ENDOCRINE, 2024, 85 (02) : 864 - 872
  • [8] Patient Frailty Should Be Used to Individualize Treatment Decisions in Primary Hyperparathyroidism
    Seib, Carolyn D.
    Chomsky-Higgins, Kathryn
    Gosnell, Jessica E.
    Shen, Wen T.
    Suh, Insoo
    Duh, Quan-Yang
    Finlayson, Emily
    WORLD JOURNAL OF SURGERY, 2018, 42 (10) : 3215 - 3222
  • [9] Patient Frailty Should Be Used to Individualize Treatment Decisions in Primary Hyperparathyroidism
    Carolyn D. Seib
    Kathryn Chomsky-Higgins
    Jessica E. Gosnell
    Wen T. Shen
    Insoo Suh
    Quan-Yang Duh
    Emily Finlayson
    World Journal of Surgery, 2018, 42 : 3215 - 3222
  • [10] How should age at diagnosis impact treatment strategy in asymptomatic primary hyperparathyroidism? A cost-effectiveness analysis
    Zanocco, Kyle
    Sturgeon, Cord
    SURGERY, 2008, 144 (02) : 290 - 298
12345